Ulta Beauty, Inc. (ULTA) At $227.93 Forms Bottom; Earnest Partners Has Decreased By $2.15 Million Its Charles River La (CRL) Holding

Charles River Laboratories International, Inc. (NYSE:CRL) Logo

Earnest Partners Llc decreased Charles River La (CRL) stake by 7.51% reported in 2017Q4 SEC filing. Earnest Partners Llc sold 19,687 shares as Charles River La (CRL)’s stock declined 1.14%. The Earnest Partners Llc holds 242,575 shares with $26.55M value, down from 262,262 last quarter. Charles River La now has $5.14B valuation. The stock increased 1.13% or $1.2 during the last trading session, reaching $107.25. About 156,246 shares traded. Charles River Laboratories International, Inc. (NYSE:CRL) has risen 21.28% since April 17, 2017 and is uptrending. It has outperformed by 9.73% the S&P500.

Ulta Beauty, Inc. (ULTA) formed multiple bottom with $207.42 target or 9.00% below today’s $227.93 share price. Ulta Beauty, Inc. (ULTA) has $13.82 billion valuation. The stock increased 3.19% or $7.05 during the last trading session, reaching $227.93. About 1.35 million shares traded or 2.37% up from the average. Ulta Beauty, Inc. (NASDAQ:ULTA) has declined 26.85% since April 17, 2017 and is downtrending. It has underperformed by 38.40% the S&P500.

Among 29 analysts covering Ulta Salon Cosmetics & Fragrance Inc (NASDAQ:ULTA), 20 have Buy rating, 0 Sell and 9 Hold. Therefore 69% are positive. Ulta Salon Cosmetics & Fragrance Inc has $350 highest and $155 lowest target. $260.32’s average target is 14.21% above currents $227.93 stock price. Ulta Salon Cosmetics & Fragrance Inc had 127 analyst reports since July 21, 2015 according to SRatingsIntel. As per Friday, August 26, the company rating was maintained by Cowen & Co. The firm has “Buy” rating by Loop Capital given on Friday, March 16. As per Friday, March 16, the company rating was maintained by BMO Capital Markets. As per Tuesday, July 11, the company rating was maintained by Oppenheimer. The stock of Ulta Beauty, Inc. (NASDAQ:ULTA) has “Buy” rating given on Friday, May 26 by BMO Capital Markets. The company was initiated on Monday, August 3 by Deutsche Bank. The firm has “Hold” rating by Deutsche Bank given on Friday, March 16. RBC Capital Markets maintained it with “Hold” rating and $31000 target in Friday, May 26 report. Raymond James downgraded the shares of ULTA in report on Monday, May 9 to “Market Perform” rating. The firm has “Hold” rating given on Wednesday, August 23 by Oppenheimer.

Investors sentiment increased to 0.95 in Q4 2017. Its up 0.10, from 0.85 in 2017Q3. It increased, as 88 investors sold Ulta Beauty, Inc. shares while 156 reduced holdings. 87 funds opened positions while 144 raised stakes. 53.45 million shares or 1.83% more from 52.49 million shares in 2017Q3 were reported. 86,898 were reported by Apg Asset Mngmt Nv. The United Kingdom-based Old Mutual Glob (Uk) Ltd has invested 0.91% in Ulta Beauty, Inc. (NASDAQ:ULTA). Legal & General Group Inc Public Ltd invested in 0.04% or 275,762 shares. Moreover, Cetera Advisor Ntwk has 0.01% invested in Ulta Beauty, Inc. (NASDAQ:ULTA). Private Ocean reported 150 shares stake. 1,800 were reported by Ksa Capital Mngmt Ltd Liability Co. State Of New Jersey Common Pension Fund D holds 33,000 shares or 0.03% of its portfolio. Synovus holds 0.06% in Ulta Beauty, Inc. (NASDAQ:ULTA) or 15,688 shares. Farmers And Merchants Inc reported 22 shares. Boston Private Wealth Ltd Liability Corp holds 5,020 shares or 0.04% of its portfolio. Levin Capital Strategies Limited Partnership holds 1,572 shares. Gradient Investments Limited Company accumulated 53 shares. Keybank Natl Association Oh holds 0% or 2,238 shares. Wealth Enhancement Advisory Ltd Liability Co stated it has 0.18% in Ulta Beauty, Inc. (NASDAQ:ULTA). Profund Ltd Liability Corp owns 5,386 shares or 0.05% of their US portfolio.

Analysts await Ulta Beauty, Inc. (NASDAQ:ULTA) to report earnings on May, 24. They expect $2.47 earnings per share, up 29.32% or $0.56 from last year’s $1.91 per share. ULTA’s profit will be $149.71M for 23.07 P/E if the $2.47 EPS becomes a reality. After $2.75 actual earnings per share reported by Ulta Beauty, Inc. for the previous quarter, Wall Street now forecasts -10.18% negative EPS growth.

Since April 5, 2018, it had 0 insider buys, and 2 sales for $8.14 million activity. Eck Dennis K also sold $4.77M worth of Ulta Beauty, Inc. (NASDAQ:ULTA) shares. The insider Dillon Mary N sold $3.37M.

Among 18 analysts covering Charles River Laboratories (NYSE:CRL), 8 have Buy rating, 1 Sell and 9 Hold. Therefore 44% are positive. Charles River Laboratories had 46 analyst reports since August 3, 2015 according to SRatingsIntel. Robert W. Baird maintained the stock with “Outperform” rating in Friday, January 8 report. The rating was upgraded by Barclays Capital on Wednesday, November 30 to “Equal Weight”. The firm has “Buy” rating given on Monday, November 13 by Robert W. Baird. The stock has “Hold” rating by Deutsche Bank on Friday, July 31. On Tuesday, June 21 the stock rating was initiated by Credit Suisse with “Neutral”. The rating was initiated by Gabelli on Tuesday, April 26 with “Buy”. Robert W. Baird maintained the stock with “Buy” rating in Thursday, August 31 report. Bank of America maintained the shares of CRL in report on Friday, November 10 with “Buy” rating. The company was upgraded on Thursday, January 7 by Wells Fargo. The firm has “Market Perform” rating by Wells Fargo given on Monday, October 12.

Investors sentiment decreased to 1.08 in Q4 2017. Its down 0.38, from 1.46 in 2017Q3. It worsened, as 35 investors sold CRL shares while 98 reduced holdings. 39 funds opened positions while 104 raised stakes. 44.57 million shares or 0.83% less from 44.95 million shares in 2017Q3 were reported. World Asset Inc holds 0.01% or 2,623 shares. Manufacturers Life Insur The reported 78,418 shares. The Connecticut-based Ellington Mngmt Gp Ltd Llc has invested 0.17% in Charles River Laboratories International, Inc. (NYSE:CRL). Shelton Capital Mgmt holds 3,442 shares or 0.02% of its portfolio. Amundi Pioneer Asset owns 0.03% invested in Charles River Laboratories International, Inc. (NYSE:CRL) for 190,070 shares. Citigroup Inc has 38,279 shares. Credit Suisse Ag has 0.01% invested in Charles River Laboratories International, Inc. (NYSE:CRL). Qs Investors Limited Liability Co holds 0.05% in Charles River Laboratories International, Inc. (NYSE:CRL) or 47,029 shares. Shell Asset Mgmt reported 22,095 shares. Putnam Invs Limited Com stated it has 0.02% in Charles River Laboratories International, Inc. (NYSE:CRL). Canada Pension Plan Inv Board invested in 195,800 shares. State Of New Jersey Common Pension Fund D invested in 35,000 shares or 0.01% of the stock. State Of Tennessee Treasury Department invested in 20,000 shares. Mason Street Advsrs Llc invested 0.06% of its portfolio in Charles River Laboratories International, Inc. (NYSE:CRL). Weaver C Barksdale And Assocs, Tennessee-based fund reported 97 shares.

Analysts await Charles River Laboratories International, Inc. (NYSE:CRL) to report earnings on May, 10 before the open. They expect $1.26 EPS, down 2.33% or $0.03 from last year’s $1.29 per share. CRL’s profit will be $60.42 million for 21.28 P/E if the $1.26 EPS becomes a reality. After $1.40 actual EPS reported by Charles River Laboratories International, Inc. for the previous quarter, Wall Street now forecasts -10.00% negative EPS growth.

Ulta Beauty, Inc. (NASDAQ:ULTA) Institutional Positions Chart

Free Email Newsletter

Enter your email address below to get the latest news and analysts’ ratings for your stocks with our free daily email newsletter: